Financial Data and Key Metrics Changes - In Q2 2025, organic ASV grew by 4.1% year-over-year, with an adjusted operating margin of 37.3% and adjusted diluted EPS of $4.28 [9][10][43] - GAAP revenues increased by 4.5% year-over-year to $571 million, while organic revenues grew by 4% to $568 million [35][36] - Free cash flow was $150 million in Q2, up 23% over the same period last year [44] Business Line Data and Key Metrics Changes - Wealth management saw double-digit growth, with significant wins including a contract with UBS [15][16] - The banking segment faced challenges, but renewal activity increased, with over a dozen large banking renewals signed [18][20] - PEVC experienced accelerated double-digit growth, while asset management faced headwinds due to cost rationalization [21][22] Market Data and Key Metrics Changes - In the Americas, organic ASV grew by 4%, while EMEA saw 3% growth and Asia-Pacific maintained 7% growth [12][13][14] - The wealth segment is gaining market share, particularly in the Americas, with expansion opportunities in Europe and Asia [16][17][118] Company Strategy and Development Direction - The company is focused on driving top-line growth, with a strong sales pipeline and product-led innovation [25][26] - Recent acquisitions, including LiquidityBook, are expected to enhance service offerings and cross-sell opportunities [23][27][111] - The strategy includes expanding into new regions and adding services to existing clients, particularly in wealth management [119] Management's Comments on Operating Environment and Future Outlook - Management acknowledges a challenging market environment but expresses confidence in the sales pipeline and product innovation [10][11] - There is optimism about growth acceleration in the second half of the fiscal year, with reaffirmed guidance for organic ASV growth [47][50] - The company is well-positioned to capitalize on Gen AI products and improve client engagement [31][50] Other Important Information - The company repurchased nearly 137,000 shares for approximately $64 million during the quarter [45] - The effective tax rate for Q2 was 15.9%, a decrease from the previous year [42] - The company is committed to returning capital to shareholders while maintaining investment-grade ratings [46][47] Q&A Session Summary Question: Can you provide more details on the traction with Gen AI products? - Management reported strong momentum with PitchCreator and other Gen AI products, with positive client reception and active trials [56][62] Question: Is the environment improving or is the company performing better in a challenging market? - Management believes they have de-risked major challenges and are seeing strength across all markets, with a positive outlook for the second half [68][71] Question: How does banking factor into the guidance range? - Management indicated that they are not relying on banking for their numbers, with conservative estimates baked into the guidance [76][80] Question: Is the UBS Vault deal included in ASV this quarter? - Yes, the UBS deal was signed in the quarter, but the ASV impact will be realized in the following quarters [84][87] Question: What is the pricing outlook given the lower CPI? - Management expects international pricing to align with the lower CPI, impacting annual price increases [90][92] Question: How are technology costs impacting margins? - Management is actively managing technology and people costs, with expectations of a ramp-up in expenses for strategic investments in the second half [96][100]

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Andrew Funderburk - Senior Vice President, Investor Relations and Strategic Finance Markus Warmuth - Chief Executive Officer Filip Janku - Chief Medical Officer Sharon Townson - Chief Scientific Officer Phil Nickson - Chief Business and Legal Officer Conference Call Participants Kelly Shi - Jefferies Edward Tenthoff - Piper Sandler Mark Fromm - TD Cowen Robert Driscoll - Wedbush Michael ...

Gambling.com Group Limited (NASDAQ:GAMB) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Peter McGough - SVP, IR & Capital Markets Charles Gillespie - Co-Founder & CEO Elias Mark - CFO Conference Call Participants Ryan Sigdahl - Craig-Hallum Capital Group Jeff Stantial - Stifel Clark Lampen - BTIG Chad Beynon - Macquarie Michael Hickey - the Benchmark Company David Katz - Jefferies Operator Greetings. Welcome to Gambling. com Group Fourth 2024 Earnings Conference Call. At this ...

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ET Company Participants Amanda Cray - IR Christian Itin - CEO Rob Dolski - CFO Conference Call Participants James Shin - Deutsche Bank Rajan Sharma - Goldman Sachs Asthika Goonewardene - Truist Matt Phipps - William Blair Gil Blum - Needham & Company Kelly Shi - Jefferies Yanan Zhu - Wells Fargo Jacob Mekhael - KBC Securities Simon Baker - Redburn Atlantic Operator Hello, ladies and gentlemen, and welcome to the A ...

VEON Ltd. (NASDAQ:VEON) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET Company Participants Anand Ramachandran - Chief of Staff Kaan Terzioglu - Group CEO Burak Ozer - Group CFO Conference Call Participants David Lopes - New Street Research Stella Cridge - Barclays Chris Hoare - New Street Research Dmitry Ivanov - Jefferies Matthew Harrigan - Benchmark Operator Hello and welcome to VEON's Full Year 2024 and Fourth Quarter 2024 Trading Update Call. We ask that you please hold all questions until ...

Yiren Digital Ltd. (NYSE:YRD) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET Company Participants Ning Tang - Founder, Chairman, Chief Executive Officer Yuning Feng - Chief Financial Officer Keyao He - Investor Relations Conference Call Participants Operator Good day, and welcome to the Yiren Digital Fourth Quarter and Fiscal Year 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to a ...

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $6.7 billion, a 3% year-on-year increase when excluding $250 million from the divested mobility business in the prior year quarter [8] - Core operating income was $334 million with core operating margins at 5% [8] - GAAP diluted earnings per share was $1.06, while core diluted earnings per share was $1.94, up $0.26 from Q2 of last year [9][30] - Adjusted free cash flow for Q2 was $261 million, bringing year-to-date adjusted free cash flow to $487 million, with expectations to exceed $1.2 billion for the year [16][37] Performance by Business Segment - Regulated Industry segment reported revenue of approximately $2.7 billion, down 8% year-on-year due to weakness in renewable energy and EV markets, but core operating margin increased to 4.8% [10] - Intelligent Infrastructure segment saw revenue of $2.6 billion, up 18% year-on-year, driven by strong demand in AI-related cloud and data center infrastructure [11] - Connected Living & Digital Commerce segment revenue was $1.3 billion, down 13% year-on-year, but grew approximately 4% when excluding the divested mobility business [12] Market Data and Key Metrics Changes - Anticipated revenue for the Intelligent Infrastructure segment in Q3 is expected to be $2.8 billion, up approximately 22% year-over-year [19] - Revenue for the Connected Living & Digital Commerce segment in Q3 is expected to be $1.2 billion, down 16% year-over-year [20] - Overall company revenue for Q3 is expected to be in the range of $6.7 billion to $7.3 billion [21] Company Strategy and Industry Competition - The company is focusing on maintaining a large-scale global manufacturing footprint to navigate geopolitical complexities and potential tariffs [25] - Jabil is well-positioned to support customers in shifting manufacturing to the U.S., with 30 sites across the country [45] - The company anticipates strong growth in AI-related business, expecting approximately $7.5 billion in revenue for FY 2025, representing a 40% year-on-year increase [31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the diversified portfolio, with certain markets like capital equipment and data center infrastructure outperforming [30] - Caution was advised regarding electric vehicles, renewables, and 5G markets due to current uncertainties [39] - The company is actively monitoring tariff situations and believes it is well-positioned to adapt to changes [38] Other Important Information - The company completed the acquisition of Pharmaceuticals International Inc., enhancing its capabilities in the pharmaceutical sector and opening a $20 billion addressable market [35] - Inventory days increased to 80 days sequentially but decreased by 7 days year-on-year, reflecting typical seasonality [13] Q&A Session Summary Question: Can you talk about your existing footprint in the US and the ability to support customers who want to move manufacturing? - Management highlighted the extensive U.S. footprint with 30 sites and the capability to quickly establish operations to support customer needs [45][46] Question: Can you elaborate on the opportunity with silicon photonics and how you see that market growing? - Management indicated strong growth in AI revenue and highlighted the acquisition from Intel that enhanced capabilities in silicon photonics [51][52] Question: What should we read into the slight reductions in networking and healthcare forecasts for fiscal 2025? - Management clarified that the reductions were primarily due to uncertainties in the 5G infrastructure market [56] Question: Can you expand on the comment about GPU racks and liquid cooling continuing to accelerate? - Management explained that improved yields at launch are driven by design architecture and engineering capabilities, with significant potential in liquid cooling solutions [101][102] Question: How confident are you about EV production for the second half of the year? - Management expressed prudence in forecasts but noted that there are positive developments in the Chinese EV market that could offset some concerns [105][106]

Financial Data and Key Metrics Changes - The company reported net revenue of $4 million in Q4 2024, a decrease from $5.9 million in Q3 2024, with a gross margin loss of $1.2 million compared to a loss of $588,000 in the same period [47][48] - Total liabilities decreased by over $18 million or nearly 50%, ending the year at $17.7 million, and net working capital improved to positive $1.6 million from a deficit of $8.8 million in the prior year [51][52] - Cash interest paid during 2024 was reduced to $722,000 compared to $1.3 million in the prior year, and overall cash burn has declined significantly [52] Business Line Data and Key Metrics Changes - The company focused on restructuring its contract manufacturing operations, which have been the primary source of revenue, and is expected to see growth in volume and sales in 2025 [25][49] - The rebranded VLN product is anticipated to begin shipping in Q2 2025, with new marketing campaigns aimed at driving sales [49][39] - The company has signed and started shipping additional CMO brands for export, while offloading unprofitable filtered cigar contracts [16] Market Data and Key Metrics Changes - The U.S. cigarette market is approximately $85 billion, with big tobacco owning about 85% of it, leaving a $12.5 billion market for other brands [30] - The company is poised to relaunch VLN and introduce partner VLN brands, which will compete for shelf space in the 15% of the market not dominated by big tobacco [31][35] Company Strategy and Development Direction - The company has repositioned itself as a pure-play tobacco company, divesting from the GVB hemp/cannabis business and focusing on the VLN product line [12][14] - The strategy includes expanding the reach of VLN to other tobacco products and developing next-generation products that fit within the VLN brand [37][40] - The company aims to achieve profitability in 2025, with a focus on revenue growth and margin improvement through CMO contracts and VLN distribution [45][46] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges faced during the turnaround process, including cash burn and operating losses, but expressed optimism about achieving breakeven in Q4 2025 [24][58] - The company is focused on executing its strategy and operations to drive sustainable growth and cash-positive operations [23][60] - Management highlighted the importance of rate of sale and customer awareness in achieving success with the VLN product line [35][39] Other Important Information - The company is actively involved in a lawsuit against Dorchester Insurance Company for $9 million in business interruption insurance claims, with a trial date set for November 2025 [53] - The FDA's proposed rule on nicotine yield could provide a favorable environment for the VLN product, as it is currently the only FDA-approved product that meets the proposed standard [40][41] Q&A Session Summary Question: Do you see stabilization of CMO contract terminations in Q1 2025? - Management indicated that the reshuffling of CMO contracts has completed, and production under new contracts is now moving forward, with expectations for breakeven in Q4 2025 [58]

PDD Holdings Inc. (NASDAQ:PDD) Q4 2024 Earnings Call March 20, 2025 7:30 AM ET Company Participants Unidentified Company Representative - Lei Chen - Chairman & Co-CEO Jiazhen Zhao - Executive Director & Co-CEO Jun Liu - VP, Finance Conference Call Participants Joyce Ju - Bank of America Securities Alicia Yap - Citigroup Kenneth Fong - UBS Operator Ladies and gentlemen, thank you for standing by, and welcome to PDD Holdings Inc. Fourth Quarter and Fiscal Year 2024 Earnings Conference Call. At this time, all ...

Designer Brands Inc. (NYSE:DBI) Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ET Company Participants Dustin Hauenstein - SVP, Finance Doug Howe - CEO Jared Poff - CFO Conference Call Participants Mauricio Serna - UBS Operator Good day, and welcome to the Designer Brands Inc. Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I'd now like to turn the conference over to Dustin Hauenstein, Senior Vice President of Finance. Please go ahead ...